New Data Demonstrate That Seno Medical’s Opto-Acoustic Imaging Technology Offers A Non-Invasive Approach to Differentiating Breast Cancer Molecular Subtypes
– Company’s technology, which shows promise as a clinical prognostic […]
Seno Medical: Making a Difference for Breast Cancer in San Antonio
– San Antonio-based technology company focuses on improving breast cancer […]
Annual Cost of False-Positive Breast Biopsies Exceeds $2 Billion According to Recent Study
– Publication in ClinicoEconomics and Outcomes Research estimates nearly $8 […]
New Analytics Approach Offers Potential of Reducing Unnecessary Breast Biopsies
– Publication in AJR defines advanced statistical methods that can […]
Opto-Acoustic Imaging Leader Seno Medical Instruments Announces Recipient of Its 8th Annual Best Paper Award during the SPIE Annual Conference
-2017 award recognizes a novel optical imaging modality that provides […]
Seno Medical Instruments Announces New Data Demonstrating That Imagio™ Opto-Acoustic Breast Imaging System Delivers Critical Diagnostic and Prognostic Information About Tumor Subtypes
– Prospective clinical study presented at the San Antonio Breast […]
Seno Medical Instruments’ Imagio™ Opto-Acoustic Breast Imaging System Demonstrates Ability to Downgrade Risk Classification of Benign Breast Masses in a Prospective European Clinical Trial
CHICAGO, November 28, 2017 – Seno Medical Instruments, Inc. (Seno Medical), […]
Pivotal Trial Data Support Potential of Seno Medical Instruments’ Imagio™ Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies
Results Presented in a High Impact Clinical Trial Session at […]
Seno Medical Instruments Investigator Speaking to Opto-Acoustic Breast Imaging as a Strong Predictor of Malignancy
Results Presented at the American Roentgen Ray Society (ARRS) Annual […]
Seno Medical Instruments Appoints Ann Waterhouse as VP, Quality Assurance and Regulatory Affairs
SAN ANTONIO, April 24, 2017 /PRNewswire/ — Seno Medical Instruments, […]